Teva- Pharmaceutical Industries Ltd. ADR (TEVA)

Schlusskurs vom Vortag:

$13.98

Offen:

$13.92

24-Stunden-Volumen:

5.57M

Marktkapitalisierung:

$15.82B

Einnahmen:

$15.85B

Nettoeinkommen (Verlust:

$-559.00M

KGV:

-7.0025

EPS:

-2

Netto-Cashflow:

$842.00M

1W Leistung:

-0.64%

1M Leistung:

-1.69%

6M Leistung:

+54.80%

1J Leistung:

+59.74%

1-Tages-Spanne:

$13.88

$14.05

52-Wochen-Spanne:

$7.085

$14.46

Teva- Pharmaceutical Industries Ltd. ADR Stock (TEVA) Company Profile

Firmenname

Teva- Pharmaceutical Industries Ltd. ADR

Sektor

Healthcare (1223)

Branche

Drug Manufacturers - Specialty & Generic (3)

Telefon

972 3 914 8171

Adresse

5 Basel Street, Petach Tikva

Mitarbeiter

51,792

Twitter

@TevaUSA

Nächster Verdiensttermin

2024-05-14

Neueste SEC-Einreichungen

TEVA's Discussions on Twitter

Teva- Pharmaceutical Industries Ltd. ADR Stock (TEVA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-02-12	Hochstufung	Piper Sandler	Neutral → Overweight
2024-01-23	Hochstufung	Jefferies	Hold → Buy
2024-01-03	Hochstufung	Piper Sandler	Underweight → Neutral
2023-12-18	Eingeleitet	HSBC Securities	Buy
2023-11-27	Hochstufung	UBS	Neutral → Buy
2023-07-06	Hochstufung	UBS	Sell → Neutral
2023-05-25	Eingeleitet	Morgan Stanley	Equal-Weight
2023-05-18	Hochstufung	Evercore ISI	In-line → Outperform
2023-01-19	Herabstufung	Jefferies	Buy → Hold
2022-11-14	Herabstufung	JP Morgan	Neutral → Underweight
2022-11-04	Herabstufung	UBS	Neutral → Sell
2022-10-21	Fortgesetzt	Jefferies	Buy
2022-08-05	Hochstufung	BofA Securities	Neutral → Buy
2022-06-14	Fortgesetzt	UBS	Neutral
2022-05-17	Hochstufung	BofA Securities	Underperform → Neutral
2022-05-04	Herabstufung	Piper Sandler	Neutral → Underweight
2022-04-05	Hochstufung	Barclays	Equal Weight → Overweight
2022-03-25	Hochstufung	Bernstein	Mkt Perform → Outperform
2022-01-27	Herabstufung	Argus	Buy → Hold
2021-10-28	Herabstufung	Raymond James	Outperform → Mkt Perform
2021-05-04	Herabstufung	UBS	Buy → Neutral
2021-04-07	Fortgesetzt	RBC Capital Mkts	Sector Perform
2020-11-25	Eingeleitet	Oppenheimer	Perform
2020-08-06	Hochstufung	Barclays	Underweight → Equal Weight
2020-07-27	Fortgesetzt	Goldman	Neutral
2020-06-01	Hochstufung	SunTrust	Hold → Buy
2020-04-24	Fortgesetzt	Citigroup	Neutral
2020-04-06	Hochstufung	UBS	Neutral → Buy
2020-02-24	Herabstufung	Edward Jones	Hold → Sell
2019-11-12	Hochstufung	JP Morgan	Underweight → Neutral
2019-10-17	Hochstufung	Gabelli & Co	Hold → Buy
2019-08-07	Herabstufung	Evercore ISI	Outperform → In-line
2019-07-19	Eingeleitet	Wolfe Research	Peer Perform
2019-07-15	Herabstufung	Morgan Stanley	Equal-Weight → Underweight
2019-07-10	Fortgesetzt	Credit Suisse	Neutral
2019-07-05	Hochstufung	Argus	Hold → Buy
2019-06-11	Eingeleitet	Barclays	Underweight
2019-06-03	Hochstufung	Oppenheimer	Perform → Outperform
2019-05-30	Herabstufung	BofA/Merrill	Buy → Underperform
2019-05-28	Herabstufung	UBS	Buy → Neutral
2019-03-20	Eingeleitet	SunTrust	Hold
2019-03-07	Fortgesetzt	UBS	Buy

Alle ansehen

Teva- Pharmaceutical Industries Ltd. ADR Aktie (TEVA) Neueste Nachrichten

Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?

Zacks Investment Research

Unlocking Q1 Potential of Teva Pharmaceutical Industries (TEVA): Exploring Wall Street Estimates for Key Metrics

Zacks Investment Research

Zacks Industry Outlook Highlights Teva, Dr. Reddy's and Viatris

Zacks Investment Research

3 Generic Drug Stocks to Watch Amid Challenging Market Prospects

Zacks Investment Research

Forget Nvidia: 3 Prominent Billionaire Investors Are Selling It and Buying These 6 Value Stocks Instead

The Motley Fool

3 No-Brainer Stocks to Buy With $600 Right Now

The Motley Fool

Finanzdaten der Teva- Pharmaceutical Industries Ltd. ADR-Aktie (TEVA)

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Umsatz 2024

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Nettogewinn 2024

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Free Cashflow 2024

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Gewinn je Aktie 2024